PC
SCMP

Paulson & Co’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Paulson & Co’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-1,600,000
Closed -$28.7M – 61
2017
Q4 		$28.7M Buy
+1,600,000
New +$19.7M 0.56% 31

Other funds holding SCMP

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Paulson & Co's SCMP Position: Q1 2018 in Review

Paulson & Co sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 1,600,000 shares — an estimated $28.7M sold.

Paulson & Co first reported a position in SCMP in Q4 2017 and held it in 1 quarter. The position peaked at $28.7M in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

  • Paulson & Co reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • Paulson & Co sold 1,600,000 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $28.7M.
  • Paulson & Co first reported a position in Sucampo Pharmaceuticals, Inc. in Q4 2017 and held it in 1 quarter.
  • Paulson & Co's Sucampo Pharmaceuticals, Inc. position peaked at $28.7M in Q4 2017.
  • 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Paulson & Co's 13F filing for Q1 2018, filed 15 May 2018.